STAT+: Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program
The "triple-G" weight loss drug, Pfizer's lung cancer trial results, and more biotech news from The Readout
All sources
- STAT News · Center
Prism News is a free news aggregator that breaks every story into Left, Center and Right perspectives — see what each side covers, what they ignore, and how the same event gets framed differently.